Currently available dosage forms and the route of administration of drugs for COVID-19 treatments
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
| Автор: | |
|---|---|
| Інші автори: | |
| Формат: | Other |
| Мова: | English |
| Опубліковано: |
Brac University
2023
|
| Предмети: | |
| Онлайн доступ: | http://hdl.handle.net/10361/18818 |
| id |
10361-18818 |
|---|---|
| record_format |
dspace |
| spelling |
10361-188182023-07-13T21:03:41Z Currently available dosage forms and the route of administration of drugs for COVID-19 treatments Ahmed, Hummam Abrar Afrose, Dr. Afrina Department of Pharmacy, Brac University Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Acute respiratory disease syndrome (ARDS) Pathology Immunopathology COVID-19 Drug transporters CYPs Remdesivir Dexamethasone Molnupiravir COVID-19 (Disease) -- Treatment This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. Cataloged from PDF version of thesis. Includes bibliographical references (pages 48-54). COVID-19 has been labeled a worldwide pandemic in 2020. The mortality rates have raised rapidly due to restricted treatment options. The COVID-19 outbreak caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is continuously expanding. In the pathophysiology of this illness, the patient's immune response is crucial. In extreme cases, the mediators of this inflammatory factor were shown to reach the cytokine at maximum amounts. Due to alterations in drug pharmacokinetics, a hyperinflammatory state can produce severe anomalies in transporters and drug metabolic machinery, resulting in unforeseen therapeutic responses. The present situation considers the necessity for medications to treat to alleviate and eliminate the epidemic. COVID-19 continues to spread internationally amidst global deployment of precautionary measures to fight the illness. Some of the medications for COVID-19 are: Remdesivir (Veklury), Bebtelovimab, Molnupiravir (Lagevrio), Nirmatrelvir with ritonavir (Paxlovid) etc. Hummam Abrar Ahmed B. Pharmacy 2023-07-13T09:51:31Z 2023-07-13T09:51:31Z 2022 2022-02 Other ID: 18146051 http://hdl.handle.net/10361/18818 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 54 pages application/pdf Brac University |
| institution |
Brac University |
| collection |
Institutional Repository |
| language |
English |
| topic |
Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Acute respiratory disease syndrome (ARDS) Pathology Immunopathology COVID-19 Drug transporters CYPs Remdesivir Dexamethasone Molnupiravir COVID-19 (Disease) -- Treatment |
| spellingShingle |
Coronavirus disease 2019 (COVID-19) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Acute respiratory disease syndrome (ARDS) Pathology Immunopathology COVID-19 Drug transporters CYPs Remdesivir Dexamethasone Molnupiravir COVID-19 (Disease) -- Treatment Ahmed, Hummam Abrar Currently available dosage forms and the route of administration of drugs for COVID-19 treatments |
| description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022. |
| author2 |
Afrose, Dr. Afrina |
| author_facet |
Afrose, Dr. Afrina Ahmed, Hummam Abrar |
| format |
Other |
| author |
Ahmed, Hummam Abrar |
| author_sort |
Ahmed, Hummam Abrar |
| title |
Currently available dosage forms and the route of administration of drugs for COVID-19 treatments |
| title_short |
Currently available dosage forms and the route of administration of drugs for COVID-19 treatments |
| title_full |
Currently available dosage forms and the route of administration of drugs for COVID-19 treatments |
| title_fullStr |
Currently available dosage forms and the route of administration of drugs for COVID-19 treatments |
| title_full_unstemmed |
Currently available dosage forms and the route of administration of drugs for COVID-19 treatments |
| title_sort |
currently available dosage forms and the route of administration of drugs for covid-19 treatments |
| publisher |
Brac University |
| publishDate |
2023 |
| url |
http://hdl.handle.net/10361/18818 |
| work_keys_str_mv |
AT ahmedhummamabrar currentlyavailabledosageformsandtherouteofadministrationofdrugsforcovid19treatments |
| _version_ |
1814307359440240640 |